News Update: Inspire Pharma Shares Down 6.5% After Eye Drug Didn't Achieve Significant Results

From: TradeTheTrend

Added: 16 years ago · 0:47 · 480p

Inspire Pharmaceuticals (NASDAQ:ISPH) shares dropped 6.5% to $6.60 after the company said that its eye drug Azasite didn't ...